¥2,686.50
1.70% today
Tokyo, Nov 17, 07:01 am CET
ISIN
JP3347200002
Symbol
4507
Index

Shionogi & Stock price

¥2,685.00
+286.00 11.92% 1M
+448.00 20.03% 6M
+466.00 21.00% YTD
+614.50 29.68% 1Y
+381.33 16.55% 3Y
+805.00 42.82% 5Y
+876.67 48.48% 10Y
+2,214.33 470.47% 20Y
Tokyo, Closing price Mon, Nov 17 2025
-48.00 1.76%
ISIN
JP3347200002
Symbol
4507
Index
Industry

New AI Insights on Shionogi & Insights AI Insights on Shionogi &

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
¥2.4t
Enterprise Value
¥1.8t
Net debt
positive
Cash
¥584.0b
Shares outstanding
851.0m
Valuation (TTM | estimate)
P/E
13.6 | 12.7
P/S
5.5 | 4.7
EV/Sales
4.2 | 3.6
EV/FCF
10.2
P/B
1.7
Dividends
DPS
¥66.00
Yield 1Y | 5Y
2.4% | 2.3%
Growth 1Y | 5Y
7.6% | 12.9%
Payout 1Y | 3Y
30.6% | 26.9%
Increased
14 Years
Financials (TTM | estimate)
Revenue
¥437.3b | ¥506.9b
EBITDA
¥158.5b | ¥196.2b
EBIT
¥155.5b | ¥136.1t
Net Income
¥170.8b | ¥183.0b
Free Cash Flow
¥181.2b
Growth (TTM | estimate)
Revenue
4.5% | 15.7%
EBITDA
17.2% | 16.6%
EBIT
18.6% | 85,331.2%
Net Income
10.5% | 7.4%
Free Cash Flow
36.2%
Margin (TTM | estimate)
Gross
85.6%
EBITDA
36.3% | 38.7%
EBIT
35.6%
Net
39.1% | 36.1%
Free Cash Flow
41.5%
Financial Health
Equity Ratio
88.7%
Return on Equity
12.5%
ROCE
10.5%
ROIC
14.2%
Debt/Equity
0.0
More
EPS
¥200.8
FCF per Share
¥213.0
Short interest
-
Employees
5k
Rev per Employee
¥88.4m
Show more

Is Shionogi & a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,042 stocks worldwide.

Shionogi & Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Shionogi & forecast:

7x Buy
41%
9x Hold
53%
1x Sell
6%

Analyst Opinions

17 Analysts have issued a Shionogi & forecast:

Buy
41%
Hold
53%
Sell
6%

Financial data from Shionogi &

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
437,263 437,263
4% 4%
100%
- Direct Costs 62,946 62,946
5% 5%
14%
374,317 374,317
4% 4%
86%
- Selling and Administrative Expenses 107,517 107,517
8% 8%
25%
- Research and Development Expense 104,223 104,223
7% 7%
24%
158,488 158,488
17% 17%
36%
- Depreciation and Amortization 2,983 2,983
28% 28%
1%
EBIT (Operating Income) EBIT 155,505 155,505
19% 19%
36%
Net Profit 170,844 170,844
11% 11%
39%

In millions JPY.

Don't miss a Thing! We will send you all news about Shionogi & directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.

Head office Japan
CEO Isao Teshirogi
Employees 4,959
Founded 1878
Website www.shionogi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today